Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1225476
PUBLISHER: IMARC | PRODUCT CODE: 1225476
Retinoblastoma Treatment Market by Type(Surgery, Radiation Therapy, Laser Therapy, Cryotherapy, Thermotherapy, Chemotherapy, Opthalmic Artery Infusion Chemotherapy, High-Dose Chemotherapy & Stem Cell Transplant, Staging) Application & Region 2023-2028
PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Market Overview:
- The global retinoblastoma treatment market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028. A considerable rise in healthcare expenditure for ophthalmic treatment procedures, increasing investments in research and development (R&D) activities on therapies with lower side effects, and the increasing health consciousness represent some of the key factors driving the market.
- Retinoblastoma is one of the most common cancers that generally develops before the age of 5 in children. Some of the symptoms of retinoblastoma include a white appearance in the pupil called cat's eye reflex or leukocoria. Retinoblastoma treatment can include a variety of drug delivery and chemotherapy techniques that provide some benefits in the short term since retinoblastoma is curable at the initial stage. Following the first or second chemotherapy cycle, different focal treatments can then be applied depending on how much the tumor shrinks and where it is in the eye. A combination of different treatment methods is the most successful retinoblastoma treatment option. Surgery is the permanent retinoblastoma treatment option as it removes the tumor thoroughly from the retina. There are a variety of imaging tests available for a detailed diagnosis of retinoblastoma, including ultrasound, CT-scan, MRI, X-ray, and bone scan.
Retinoblastoma Treatment Market Trends:
- A considerable rise in healthcare expenditure for ophthalmic treatment procedures is a significant factor driving the market. This can be attributed to the rising incidences of retinoblastoma among the younger population. In line with this, increasing investments in research and development (R&D) activities focusing on newer, more efficient therapeutic strategies with lesser associated side effects is providing an impetus to the market. Moreover, the growing awareness regarding different type of cancers resulting in higher diagnosis and treatment rates are also acting as a significant growth-inducing factor. However, the lack of availability of various retinoblastoma treatment drugs, along with stringent drug regulations, are acting as a growth-restraining factor for the market. On the contrary, the increasing number of product approvals leading to the launches of new drug variants is creating a positive outlook for the market. Besides this, the growing rates of recurrence of retinoblastoma are also creating lucrative opportunities in the retinoblastoma treatment market. The market is further propelled by various organic growth strategies undertaken by key payers, such as partnerships and collaborations, and merger and acquisitions (M&As). Apart from this, the presence of strong pipeline drugs, along with the augmenting number of clinical trials, are fueling the market growth. Some of the other factors contributing to the market include rapid urbanization, inflating disposable income levels, considerable growth in cancer research, and improvements in medical infrastructure across the globe.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each segment of the global retinoblastoma treatment market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on type, treatment type, type of staging, and application.
Type Insights:
- Non-Hereditary Retinoblastoma
- Hereditary Retinoblastoma
- The report has provided a detailed breakup and analysis of the retinoblastoma treatment market based on the type. This includes non-hereditary retinoblastoma and hereditary retinoblastoma. According to the report, non-hereditary retinoblastoma represented the largest segment.
Treatment Type Insights:
- Surgery
- Radiation Therapy
- Laser Therapy (Photocoagulation)
- Cryotherapy
- Thermotherapy
- Chemotherapy
- Opthalmic Artery Infusion Chemotherapy
- High-Dose Chemotherapy and Stem Cell Transplant
- The report has provided a detailed breakup and analysis of the retinoblastoma treatment market based on the treatment type. This includes surgery, radiation therapy, laser therapy (photocoagulation), cryotherapy, thermotherapy, chemotherapy, opthalmic artery infusion chemotherapy, and high-dose chemotherapy and stem cell transplant. According to the report, chemotherapy represented the largest segment.
Type of Staging Insights:
- Intraocular Retinoblastoma
- Extraocular Retinoblastoma
- The report has provided a detailed breakup and analysis of the retinoblastoma treatment market based on the type of staging. This includes intraocular retinoblastoma and extraocular retinoblastoma. According to the report, intraocular retinoblastoma represented the largest segment.
Application Insights:
- Hospitals
- Cancer Institutes
- Others
- A detailed breakup and analysis of the retinoblastoma treatment market based on the application has also been provided in the report. This includes hospitals, cancer institutes, and others.
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
- The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for retinoblastoma treatment. Some of the factors driving the Asia Pacific retinoblastoma treatment market include the growing rates of recurrence of retinoblastoma, higher diagnosis and treatment rates due to the increasing awareness regarding different types of cancers, the presence of several key players in the region, etc.
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the global retinoblastoma treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bristol Myers Squibb Company, Pfizer Inc., Teva Canada Limited (Teva Pharmaceutical Industries Ltd.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global retinoblastoma treatment market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global retinoblastoma treatment market?
- What are the key regional markets?
- Which countries represent the most attractive retinoblastoma treatment markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the type of staging?
- What is the breakup of the market based on application?
- What is the competitive structure of the global retinoblastoma treatment market?
- Who are the key players/companies in the global retinoblastoma treatment market?
Product Code: SR1423A317_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Retinoblastoma Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Non-Hereditary Retinoblastoma
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Hereditary Retinoblastoma
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Treatment Type
- 7.1 Surgery
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Radiation Therapy
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Laser Therapy (Photocoagulation)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Cryotherapy
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Thermotherapy
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Chemotherapy
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Opthalmic Artery Infusion Chemotherapy
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
- 7.8 High-Dose Chemotherapy and Stem Cell Transplant
- 7.8.1 Market Trends
- 7.8.2 Market Forecast
8 Market Breakup by Type of Staging
- 8.1 Intraocular Retinoblastoma
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Extraocular Retinoblastoma
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Application
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Cancer Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
- 11.1 Overview
- 11.2 Drivers
- 11.3 Restraints
- 11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Bristol Myers Squibb Company
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Pfizer Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Teva Canada Limited (Teva Pharmaceutical Industries Ltd.)
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.1 Bristol Myers Squibb Company
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Product Code: SR1423A317_Report
List of Figures
- Figure 1: Global: Retinoblastoma Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Retinoblastoma Treatment Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Retinoblastoma Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Retinoblastoma Treatment Market: Breakup by Type (in %), 2022
- Figure 5: Global: Retinoblastoma Treatment Market: Breakup by Treatment Type (in %), 2022
- Figure 6: Global: Retinoblastoma Treatment Market: Breakup by Type of Staging (in %), 2022
- Figure 7: Global: Retinoblastoma Treatment Market: Breakup by Application (in %), 2022
- Figure 8: Global: Retinoblastoma Treatment Market: Breakup by Region (in %), 2022
- Figure 9: Global: Retinoblastoma Treatment (Non-Hereditary Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Retinoblastoma Treatment (Non-Hereditary Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Retinoblastoma Treatment (Hereditary Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Retinoblastoma Treatment (Hereditary Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Retinoblastoma Treatment (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Retinoblastoma Treatment (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Retinoblastoma Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Retinoblastoma Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Retinoblastoma Treatment (Laser Therapy (Photocoagulation)) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Retinoblastoma Treatment (Laser Therapy (Photocoagulation)) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Retinoblastoma Treatment (Cryotherapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Retinoblastoma Treatment (Cryotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Retinoblastoma Treatment (Thermotherapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Retinoblastoma Treatment (Thermotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Retinoblastoma Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Retinoblastoma Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Retinoblastoma Treatment (Opthalmic Artery Infusion Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Retinoblastoma Treatment (Opthalmic Artery Infusion Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Retinoblastoma Treatment (High-Dose Chemotherapy and Stem Cell Transplant) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Retinoblastoma Treatment (High-Dose Chemotherapy and Stem Cell Transplant) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Retinoblastoma Treatment (Intraocular Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Retinoblastoma Treatment (Intraocular Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: Global: Retinoblastoma Treatment (Extraocular Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: Global: Retinoblastoma Treatment (Extraocular Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: Global: Retinoblastoma Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: Global: Retinoblastoma Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Global: Retinoblastoma Treatment (Cancer Institutes) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Global: Retinoblastoma Treatment (Cancer Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Global: Retinoblastoma Treatment (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Global: Retinoblastoma Treatment (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: North America: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: North America: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: United States: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: United States: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: Canada: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: Canada: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: Asia-Pacific: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: Asia-Pacific: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: China: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: China: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Japan: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Japan: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: India: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: India: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: South Korea: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: South Korea: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Australia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Australia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Indonesia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Indonesia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Europe: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Europe: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Germany: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Germany: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: France: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: France: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: United Kingdom: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: United Kingdom: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Italy: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Italy: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Spain: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Spain: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Russia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Russia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Latin America: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Latin America: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Brazil: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 80: Brazil: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: Mexico: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 82: Mexico: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 83: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 84: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 85: Middle East and Africa: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 86: Middle East and Africa: Retinoblastoma Treatment Market: Breakup by Country (in %), 2022
- Figure 87: Middle East and Africa: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 88: Global: Retinoblastoma Treatment Industry: Drivers, Restraints, and Opportunities
- Figure 89: Global: Retinoblastoma Treatment Industry: Value Chain Analysis
- Figure 90: Global: Retinoblastoma Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Retinoblastoma Treatment Market: Key Industry Highlights, 2022 & 2028
- Table 2: Global: Retinoblastoma Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
- Table 3: Global: Retinoblastoma Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
- Table 4: Global: Retinoblastoma Treatment Market Forecast: Breakup by Type of Staging (in Million US$), 2023-2028
- Table 5: Global: Retinoblastoma Treatment Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 6: Global: Retinoblastoma Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Retinoblastoma Treatment Market: Competitive Structure
- Table 8: Global: Retinoblastoma Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.